摘要
目的探讨丹参川嗪治疗慢性肺源性心脏病的疗效。方法选择在我院接受治疗的慢性肺性心脏病患者100例,随机分为观察组与对照组,观察组在常规治疗的同时注射丹参川穹嗪注射液,两周为一疗程。结果观察组呼吸频率、动脉血氧气压与对照组患者比较均有明显好转。结论丹参川穹嗪是治疗慢性肺源性心脏病的较好的辅助药物。
Objective To investigate the effect of Danshen Ligustrazine on patients with chronic pulmonary heart disease. Methods 100 cases of chronic pulmonary heart disease patients in our hospital were randomly divided into observation group and control group, the observation group was treated with the conventional treatment and injection of Danshen Ligustrazin injection, took two weeks as a course of treatment. Results In the observation group, the respiratory rate, arterial oxygen pressure were obviously improved than control group. Conclusion Danshen Ligustrazine is a helpful aided medicine in treating chronic pulmonary heart disease.
出处
《中国继续医学教育》
2015年第4期251-251,共1页
China Continuing Medical Education
关键词
丹参川穹嗪
临床治疗
慢性肺源性心脏病
Danshen Ligustrazine
Clinical effect
Chronic pulmonary heart disease
